Nerium International established a Scientific Advisory Board, comprised of the following scientists and dermatologists: Dr. Adam Friedman, Dr. Neal Bhatia, Dr. Mira Stotland, Marie Bertrand, Dr. Debra J. Wattenberg, and Dr. Karthik Krishnamurthy. The mission of the Nerium International Scientific Advisory Board is to educate consumers about the efficacy and safety of Nerium's products while also providing feedback on new product development, according to the company.

The Scientific Advisory Board will be chaired by Adam Friedman, MD, FAAD and Director of Dermatologic Research at the Unified Division of Dermatology of Montefiore Medical Center - Albert Einstein College of Medicine.

"One of my main professional goals is to help advance science and research in the skincare field—a mission shared by Nerium International. My contribution to the Scientific Advisory Board will provide an opportunity to support that mission," said Dr. Friedman. "I look forward to working alongside these five noteworthy individuals as a part of Nerium's new Scientific Advisory Board."

The Nerium International Scientific Advisory Board includes:

Dr. Adam Friedman: Board-certified dermatologist, Director of Dermatologic Research and Assistant Professor of Medicine (dermatology), physiology and biophysics at the Unified Division of Dermatology of Montefiore Medical Center - Albert Einstein College of Medicine in New York, NY.

Dr. Neal Bhatia: Board-certified dermatologist and Clinical Director of Dermatology at Therapeutics Clinical Research in San Diego, CA and Interim Program Director at Harbor-UCLA Medical Center in Torrance, CA.

Dr. Mira Stotland: Board-certified dermatologist, specialist in skin cancer prevention and treatment, cosmetic dermatology and laser surgery in Los Angeles, CA.

Marie Bertrand: Microbiologist, Skin Scientist and Founder of SkinScience Center in Calgary, AB, Canada.

Dr. Debra J. Wattenberg: Board-certified dermatologist, dermatologic surgeon and Associate Clinical Professor of Dermatology at the Mount Sinai Medical Center in New York, NY.

Dr. Karthik Krishnamurthy: Board-certified dermatologist, Associate Professor of Dermatology at Albert Einstein College of Medicine in New York, NY.

"We're excited to have an advisory board committed to sharing and exploring the full potential of Nerium products to ensure excellent customer satisfaction and exceptional skincare results," said Jeff Olson, Co-Founder and CEO of Nerium International.

With the primary goal of product safety and quality, Nerium has taken great care with respect to the formulation of its products. Nerium's product portfolio includes the NeriumAD product line, sold in the United States, and the Optimera product line, sold internationally.

NeriumAD products were formulated after more than 10 years of scientific research and clinical testing by scientists and medical professionals, the company says. The products include the exclusive, patented NAE-8 extract, derived from the Nerium oleander plant and Aloe. The NeriumAD product line includes: NeriumAD Age-Defying Day Cream, NeriumAD Age-Defying Treatment Night Cream and NeriumFirm Body Contouring Cream.

The Optimera product line was developed following the same formulation guidelines and clinical testing as the NeriumAD line and features the patent-pending SAL-14 extract. The SAL-14 extract is a botanically-based blend featuring Biden pilosa, an ingredient known for its advanced age-fighting properties. This line includes the Optimera Day Cream and Optimera Night Cream.

Both the NeriumAD and Optimera products have been proven to reduce the appearance of fine lines and wrinkles, discoloration, uneven skin texture, enlarged pores and aging skin without the use of harmful ingredients.